subscribeSubscribe
price-trendAsk Us
HiberCell: First Patient Dosed In Merck Combo Trial For ccRCC

HiberCell: First Patient Dosed In Merck Combo Trial For ccRCC
GLOBENEWSWIRE
01 May 2024
Share Share
US FDA approves Merck`s drug for kidney cancer

US FDA approves Merck`s drug for kidney cancer
REUTERS
14 Dec 2023
Share Share
At ESMO, Merck touts Welireg`s potential in kidney cancer

At ESMO, Merck touts Welireg`s potential in kidney cancer
Kevin Dunleavy FIERCE PHARMA
21 Oct 2023
Share Share
Merck’s WELIREG Improved Objective Response Rates Versus Everolimus in RCC

Merck’s WELIREG Improved Objective Response Rates Versus Everolimus in RCC
BUSINESSWIRE
21 Oct 2023
Share Share
FDA Accepts for Priority Review Merck’s Supplemental NDA for WELIREG

FDA Accepts for Priority Review Merck’s Supplemental NDA for WELIREG
BUSINESSWIRE
19 Sep 2023
Share Share